113 results Stibbe advises Forbion Capital Partners Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding. Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products. Stibbe advises on the contemplated IPO of Agendia Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency. Stibbe advises on the IPO of Tornier Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix. Stibbe defends KLM against greenwashing claims Fossielvrij NL has launched a greenwashing claim against Royal Dutch Airlines KLM, the first of its kind to be brought under the Dutch collective action regime. Game over for dark patterns? ACM fines Epic for unfairly targeting children The ACM has fined Epic Games for exploiting children’s psychological vulnerabilities, marking a key moment for Dutch consumer law enforcement. Our briefing examines the broader implications for consumer-facing businesses, especially those in online sales. Stibbe assists a leading mining and metal manufacturer Stibbe assisted the president of the board of a leading mining and metal manufacturer in proceedings before the Financial Services and Markets Authority (FSMA) concerning a market manipulation case and a related criminal inquiry. The latest Legal Updates straight to your mailbox We publish high-quality legal knowledge and insights on our website on a daily basis. If you would like to be promptly informed about the latest developments within your areas of interest, we invite you to sign up for our Legal Updates. De laatste Legal Updates direct in uw mailbox Dagelijks publiceren wij op onze website hoogwaardige juridische kennis en vooruitzichten. Wilt u snel op de hoogte zijn van de meest actuele ontwikkelingen binnen uw interessegebieden? Meld u dan aan voor onze Legal Updates. Les dernières actualités juridiques directement dans votre boîte e-mail Vous souhaitez recevoir rapidement les informations concernant les derniers développements dans les domaines qui vous intéressent? Nous vous invitons à vous inscrire à nos Legal Updates. Mondelēz’s fine takes the biscuit: cross-border trade crusade peaks The European Commission has fined Mondelēz EUR 337.5 million for restricting cross-border trade. Brand owners are advised to double-check their licensing and distribution systems, as well as their commercial conduct, for possible territorial restraints. Het WODC-rapport over zelfonderzoek en zelfmelden: what’s next? Hester Bisscheroux en Amelie Borel Rinkes lichten toe waarom het onterecht is dat de minister de bevindingen uit recent gepubliceerde onderzoeksrapport 'Zelfonderzoek en zelfmelden van fraude en corruptie door bedrijven' voorlopig naast zich neer legt. Legal Considerations for Artificial Intelligence in the Life Sciences Sector This blogpost explores the evolving legal landscape governing AI in life sciences, with a focus on medical device regulation, data protection and intellectual property. Private Investigation Act - Unpacking the Scope and Key Requirements This seminar, the first in our 2025 TMT seminar series, examines the new Belgian Private Investigation Act ("Wet tot regeling van de private opsporing" / "Loi réglementant la recherche privée"), which came into effect in December 2024. Happy first anniversary! One year of the Vifo Act: an update On the first of June, the Dutch national security investment screening regime (the Vifo Act) celebrated its first anniversary. Time to take stock of key findings and forthcoming developments. Pagination Previous page Page 4 Page 5 Current page 6 Page 7 Next page
Stibbe advises Forbion Capital Partners Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding.
Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.
Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.
Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.
Stibbe defends KLM against greenwashing claims Fossielvrij NL has launched a greenwashing claim against Royal Dutch Airlines KLM, the first of its kind to be brought under the Dutch collective action regime.
Game over for dark patterns? ACM fines Epic for unfairly targeting children The ACM has fined Epic Games for exploiting children’s psychological vulnerabilities, marking a key moment for Dutch consumer law enforcement. Our briefing examines the broader implications for consumer-facing businesses, especially those in online sales.
Stibbe assists a leading mining and metal manufacturer Stibbe assisted the president of the board of a leading mining and metal manufacturer in proceedings before the Financial Services and Markets Authority (FSMA) concerning a market manipulation case and a related criminal inquiry.
The latest Legal Updates straight to your mailbox We publish high-quality legal knowledge and insights on our website on a daily basis. If you would like to be promptly informed about the latest developments within your areas of interest, we invite you to sign up for our Legal Updates.
De laatste Legal Updates direct in uw mailbox Dagelijks publiceren wij op onze website hoogwaardige juridische kennis en vooruitzichten. Wilt u snel op de hoogte zijn van de meest actuele ontwikkelingen binnen uw interessegebieden? Meld u dan aan voor onze Legal Updates.
Les dernières actualités juridiques directement dans votre boîte e-mail Vous souhaitez recevoir rapidement les informations concernant les derniers développements dans les domaines qui vous intéressent? Nous vous invitons à vous inscrire à nos Legal Updates.
Mondelēz’s fine takes the biscuit: cross-border trade crusade peaks The European Commission has fined Mondelēz EUR 337.5 million for restricting cross-border trade. Brand owners are advised to double-check their licensing and distribution systems, as well as their commercial conduct, for possible territorial restraints.
Het WODC-rapport over zelfonderzoek en zelfmelden: what’s next? Hester Bisscheroux en Amelie Borel Rinkes lichten toe waarom het onterecht is dat de minister de bevindingen uit recent gepubliceerde onderzoeksrapport 'Zelfonderzoek en zelfmelden van fraude en corruptie door bedrijven' voorlopig naast zich neer legt.
Legal Considerations for Artificial Intelligence in the Life Sciences Sector This blogpost explores the evolving legal landscape governing AI in life sciences, with a focus on medical device regulation, data protection and intellectual property.
Private Investigation Act - Unpacking the Scope and Key Requirements This seminar, the first in our 2025 TMT seminar series, examines the new Belgian Private Investigation Act ("Wet tot regeling van de private opsporing" / "Loi réglementant la recherche privée"), which came into effect in December 2024.
Happy first anniversary! One year of the Vifo Act: an update On the first of June, the Dutch national security investment screening regime (the Vifo Act) celebrated its first anniversary. Time to take stock of key findings and forthcoming developments.